PrognosisLength of StayPolymorphism, Restriction Fragment LengthSurvival AnalysisRetrospective StudiesSurvival RateTumor Markers, BiologicalFollow-Up StudiesTreatment OutcomeNeoplasm StagingTime FactorsKaplan-Meier EstimateImmunohistochemistryBreast NeoplasmsMultivariate AnalysisProspective StudiesPredictive Value of TestsDisease-Free SurvivalProportional Hazards ModelsRisk FactorsLymphatic MetastasisGene Expression Regulation, NeoplasticAdenocarcinomaDisease ProgressionMolecular Sequence DataTelomereBase SequenceNeoplasm InvasivenessCohort StudiesNeoplasm Recurrence, LocalLung NeoplasmsCell Line, TumorAge FactorsPolymerase Chain ReactionCarcinoma, Squamous CellLiver NeoplasmsMutationNeoplasm MetastasisGene Expression ProfilingAxial Length, EyeRecurrenceStomach NeoplasmsCombined Modality TherapyCarcinomaRNA, MessengerTissue Array AnalysisRisk AssessmentCarcinoma, HepatocellularSeverity of Illness IndexBiological MarkersTomography, X-Ray ComputedNeoplasm GradingBrain NeoplasmsReverse Transcriptase Polymerase Chain ReactionColorectal NeoplasmsEsophageal NeoplasmsReproducibility of ResultsNeoplasm ProteinsInfant, NewbornSensitivity and SpecificityPregnancyGenotypeAntineoplastic Combined Chemotherapy ProtocolsCase-Control StudiesAmplified Fragment Length Polymorphism AnalysisChi-Square DistributionAmino Acid SequenceAcute DiseaseImmunoenzyme TechniquesReceptor, erbB-2Sequence Analysis, DNAPancreatic NeoplasmsAntineoplastic AgentsTelomere ShorteningPhenotypeNeoplasmsHeart FailureTelomere HomeostasisPolymorphism, GeneticDNARegression AnalysisMyocardial InfarctionMelanomaDNA, NeoplasmOvarian NeoplasmsOligonucleotide Array Sequence AnalysisIncidenceIn Situ Hybridization, FluorescenceModels, BiologicalKi-67 AntigenAnalysis of VarianceReceptors, EstrogenBiopsyTumor Suppressor Protein p53SarcomeresAdenocarcinoma, MucinousCarcinoma, Non-Small-Cell LungKidney NeoplasmsSkin NeoplasmsFatal Outcome